Navigation Links
Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
Date:11/6/2010

THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., Nov. 6, 2010 /PRNewswire/ -- Amgen Inc. (Nasdaq: AMGN), Pfizer Inc. (NYSE: PFE) and world-class professional golfer Phil Mickelson, have entered into a partnership to share Phil's experience with his diagnosis of psoriatic arthritis and treatment with Enbrel® (etanercept), and to encourage patients with similar symptoms to visit their doctor for proper assessment and care.

"This partnership with Amgen and Pfizer is important because being a psoriatic arthritis patient has motivated me to share my story," said Phil Mickelson. "I hope to encourage other patients to work with their doctors, learn about their condition and take action so that they have an opportunity to get back to some of the things that matter most to them."

Psoriatic arthritis is a form of arthritis caused by an overactive immune system that can affect not only the body's joints but also the skin. Approximately 600,000 Americans may have psoriatic arthritis. The main joint symptoms of psoriatic arthritis are pain, stiffness and swelling. Rheumatoid arthritis patients experience similar symptoms, however there are important differences between the two conditions, making it important to see a doctor.

Amgen and Pfizer were inspired by Mickelson's approach to managing his condition and by his continued drive to maintain his health. Those same qualities have kept him on top of the competitive world of golf and this is why the companies are excited to be partnering with him. Amgen and Pfizer believe his perseverance in the face of adversity will encourage patients to also work with their doctors to manage their condition and help them get back on course.

Further details and timing of future partnership initiatives will be announced in 2011.

About ENBRELE
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
2. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
3. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
4. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
5. Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond
6. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
7. Professional Liability Costs for Hospitals and Physicians Continue to Rise, Outpacing Inflation
8. UBM Medica Presents Diagnostic Imaging LIVE, a Virtual Conference for Radiologists and Imaging Professionals - Now Available On Demand
9. Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya
10. Octapharma USA Launches Web Resource for von Willebrand Disease Healthcare Professionals and Patients
11. New Hope in Austin, Texas for Children Dealing with Social, Academic and Behavioral Issues; Austin Brain Balance Achievement Centers Grand Opening to Include Lectures for Parents, Teachers and Health Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Research and Markets has announced ... Hypercholesterolemia Drugs" report to their offering. ... cholesterol burden despite the presence of many cholesterol-lowering drugs ... statins have been ubiquitously prescribed over the last 25 ... cholesterol (LDLC) is the cornerstone of assessing heart risk. ...
(Date:9/22/2014)... 2014 Persistence Market Research ( ... Study on Ophthalmic Devices: Asia ... market was valued at USD 29,171.5 million in 2014 and ... from 2014 to 2020, to reach an estimated value ... the full Global Market Study on Ophthalmic Devices:  Asia ...
(Date:9/22/2014)... Md. , Sept. 22, 2014  Neuralstem, Inc. (NYSE ... MD, site investigator at Emory University, presented long-term follow ... human neural stem cells in the treatment of amyotrophic ... The presentation, which occurred at the Annual Symposium on ... Canada , on Friday, and was not open ...
Breaking Medicine Technology:PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4
... 14, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. ... Inc.) ("China Botanic" or the "Company"), a developer, ... traditional Chinese medicines ("TCM") in China, today announced ... Enterprise assessment, and that as a result, China ...
... 14, 2011 Reportlinker.com announces that a new ... Global Cardiac Monitoring Systems Market ... With advancements in technology, innovative product offerings ... introduced in the Cardiac Monitoring Systems market. Further, ...
Cached Medicine Technology:China Botanic Pharmaceutical Receives a Tax Exemption in 2011 2China Botanic Pharmaceutical Receives a Tax Exemption in 2011 3Reportlinker Adds Global Cardiac Monitoring Systems Market -2013 2Reportlinker Adds Global Cardiac Monitoring Systems Market -2013 3
(Date:9/22/2014)... The “ Ztylus ” was featured on NewsWatch ... reviews and features the latest technology gadgets and services available ... expert, conducted the review and shared with viewers how it’s ... gives users four lens options for their camera. , The ... Tech Report, which reviews and features the latest technology gadgets ...
(Date:9/22/2014)... participate in athletics will be asked to sign a ... ensure parents are confident about handling the injury, according ... Hospital National Poll on Children,s Health. , In the ... and high school children surveyed reported participation in some ... read a brochure or online information, 17% have ...
(Date:9/22/2014)... Riverside is one of 11 collaborating institutions that have ... National Science Foundation for a project ... that include plant symbionts, animal and human pathogens and ... Zygomycetes, used in numerous industrial processes and fermentation of ... fungi. Symbiotic associations with zygomycetes may have facilitated the ...
(Date:9/22/2014)... IsoComforter, Inc., one of the Nation’s ... introduction of an innovative IsoTube technology and uniflow technology ... IsoTube ridges provide optimal contact and pain control. By ... insulated fluid reservoir to a pad that is applied ... provides continuous cold therapy for an extended period of ...
(Date:9/22/2014)... PA (PRWEB) September 22, 2014 The ... the company to lead the start-up in developing content ... Jenny brings to the company over 15 years of ... 5 star resort spa management with companies including Orient ... transitioning into the role of educator, Jenny gained extensive ...
Breaking Medicine News(10 mins):Health News:NewsWatch Recently Featured the Phone Case “Ztylus” on National Television 2Health News:Some concussion education more useful than others, parents say 2Health News:Project launched to study evolutionary history of fungi 2Health News:Project launched to study evolutionary history of fungi 3Health News:Project launched to study evolutionary history of fungi 4Health News:IsoComforter Cold Therapy Introduces Innovative IsoTube Technology 2Health News:The Spa Standard Appoints Vice-President of Content and Course Development 2
... Feb. 14 A new water purification,technology by ... of,outdoor hydration and sanitation products, and Procter & ... retail stores throughout the United States. The,product, PUR(TM) ... water clarifier and disinfectant designed for outdoor recreation,and ...
... LodgeNet,Interactive Corporation (Nasdaq: LNET ) announced ... after market on Wednesday, February 20, 2008., ... also host a teleconference to discuss its results,February ... access the teleconference,please dial 888-546-9658 and use conference ...
... Exchange Symbol: CYT, MONTREAL, Feb. 14 /PRNewswire-FirstCall/ ... products to treat cardiac,arrhythmias, today provided an update ... its inception 13 years ago CryoCath has been, ... in the field of cryotherapy devices with,cardiac applications ...
... 14 US Oncology Holdings, Inc. and its,operating ... quarter,and year-end financial results on Thursday, February 28, ... cast has been scheduled at 10:00,a.m., EST, for ... release. In this call, representatives of US Oncology,s ...
... investments in Kaiser Permanente care delivery system and ... ongoing community benefit programs, OAKLAND, Calif., ... their subsidiaries (KFHP/H) today,reported total operating revenue for the fourth quarter ... for the fourth quarter,of 2006, and a net loss of $233 ...
... China, Feb. 14 /Xinhua-PRNewswire-FirstCall/ --,Renhuang Pharmaceuticals, Inc. ... a leading pharmaceutical company in China, today ... design and execute its investor relations,campaign., ... manufactures over 200,types of western, traditional Chinese ...
Cached Medicine News:Health News:New Water Purification Product from Reliance Products and Procter & Gamble now Available in Retail Stores 2Health News:New Water Purification Product from Reliance Products and Procter & Gamble now Available in Retail Stores 3Health News:LodgeNet Interactive Corporation 2007 Earnings Release and Teleconference Announcement 2Health News:CryoCath Provides Update on Patent Infringement Lawsuit 2Health News:CryoCath Provides Update on Patent Infringement Lawsuit 3Health News:Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year-End 2007 Financial Results 2Health News:Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year-End 2007 Financial Results 3Health News:Kaiser Foundation Health Plan and Hospitals Reports Fourth Quarter and Fiscal Year-End 2007 Financial Results 4Health News:Renhuang Pharmaceuticals, Inc. Retains CCG Elite 2Health News:Renhuang Pharmaceuticals, Inc. Retains CCG Elite 3Health News:Renhuang Pharmaceuticals, Inc. Retains CCG Elite 4
... Ruschelit® PVC siliconized. Stainless steel spiral ... band. Single use. Adjustable Flange: The flange ... to suit the thickness of the cervical ... clockwise until the flange is tightly connected ...
Bivona® Uncuffed Neonatal and Pediatric Silicone Tracheostomy Tubes....
... The TTS™ tracheostomy tubes are available in ... tube is like an uncuffed tube, but it ... tight to the shaft of the tube. , ... an uncuffed tube with the insurance of a ...
... Adjustable neck flange tracheostomy ... use until the proper length ... be obtained. , ,Adjustable ... can be adjusted for both ...
Medicine Products: